Report Library
View More
Datamonitor Healthcare I&I Disease ...
September 23, 2022
Datamonitor Healthcare Infectious D...
September 23, 2022
Datamonitor Healthcare I&I Disease ...
September 23, 2022
Datamonitor Healthcare Infectious D...
September 22, 2022
Datamonitor Healthcare CNS Disease ...
September 21, 2022
Datamonitor Healthcare Infectious D...
September 19, 2022
Datamonitor Healthcare CV&Met Disea...
September 14, 2022
Datamonitor Healthcare CNS Disease ...
September 12, 2022
Datamonitor Healthcare CNS Disease ...
September 8, 2022
Datamonitor Healthcare Infectious D...
September 6, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 9/26/22 | Arcutis (ARQT) | ARQ-154 for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/23/22 | AstraZeneca (AZN) | AZD8233 for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/22/22 | Spectrum Pharmaceuticals (SPPI) | Poziotinib for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/22/22 | Oncopeptides AB (ONCO) | Pepaxto for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/22/22 | Ferring | Rebyota for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 09/27/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
| 09/27/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 09/28/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 09/28/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 09/28/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
